Document Detail


Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure.
MedLine Citation:
PMID:  10421138     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In previous animal studies, arteriovenous CO2 removal (AVCO2R) achieved significant reduction in ventilator pressures and improvement in the Pao2 to fraction of inspired oxygen ratio during severe respiratory failure. For our initial clinical experience, 5 patients were approved for treatment of severe respiratory failure and CO2 retention to evaluate the feasibility and safety of percutaneous AVCO2R. METHODS: Patients were anticoagulated with heparin (activated clotting time, 260 to 300 seconds), underwent percutaneous femoral cannulation (10F to 12F arterial and 12F to 15F venous catheters), and then were connected to a low-resistance, 2.5-m2 hollow-fiber oxygenator for 72 hours. RESULTS: Mean AVCO2R flow at 24, 48, and 72 hours was 837.4+/-73.9, 873+/-83.6, and 750+/-104.5 mL/min, respectively, with no vascular complications and no significant change in heart rate or mean arterial pressure. Removal of CO2 plateaued at an AVCO2R flow of 1086 mL/min with 208 mL/min CO2 removed. Average CO2 transfer at 24 and 48 hours was 142+/-17 and 129+/-16 mL/min. Use of AVCO2R allowed a significant decrease in minute ventilation from 7.2+/-2.3 L/min at baseline to 3.4+/-0.8 L/min at 24 hours. CONCLUSIONS: All patients survived the experimental period without adverse sequelae. Percutaneous AVCO2R can achieve approximately 70% CO2 removal in adults with severe respiratory failure and CO2 retention without hemodynamic compromise or instability.
Authors:
J B Zwischenberger; S A Conrad; S K Alpard; L R Grier; A Bidani
Related Documents :
8988998 - Comparison of end-tidal and arterial carbon dioxide in infants using laryngeal mask air...
6234978 - Capnography in the early diagnosis of carbon dioxide embolism during laparoscopy.
18044278 - The accuracy of non-invasive nasal capnography in morbidly obese patients after bariatr...
15679128 - The valid time of soda lime could be safely prolonged according to the inspired pressur...
15535138 - Functional outcomes of reduced hyaluronan in acute vocal fold scar.
23684248 - Delayed diagnosis of hypertension in diabetic patients monitored in primary care.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  68     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1999 Jul 
Date Detail:
Created Date:  1999-08-02     Completed Date:  1999-08-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  181-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, University of Texas Medical Branch and Shriners Burns Institute, Galveston 77555-0528, USA. jzwische@utmb.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Arteriovenous Shunt, Surgical
Carbon Dioxide / blood
Extracorporeal Membrane Oxygenation / adverse effects,  methods*
Feasibility Studies
Humans
Respiration, Artificial
Respiratory Distress Syndrome, Adult / blood,  therapy*
Chemical
Reg. No./Substance:
124-38-9/Carbon Dioxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rejection with heart failure after pediatric cardiac transplantation.
Next Document:  Extent of chest wall invasion and survival in patients with lung cancer.